EGFR and colon cancer: a clinical view.

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
J de Castro-CarpeñoM González Barón

Abstract

Signalling pathways that emerge from EGFR activation are critical in colon cancer (CC) biology. Its targeting with specific drugs has opened a new window in the treatment of this disease. In this regard, monoclonal antibodies (mAb) have evidenced a high degree of efficiency opposed to the uselessness of tyrosine-kinase inhibitors. Cetuximab is the mAb that has evidenced most activity in CC. After its initial approval as an irinotecan-resistance reversal agent, cetuximab has demonstrated its efficiency from the first line to heavily pretreated patients. In the first line, its addition may increase response rate to chemotherapy, improving liver metastases resection rate. Another promising approach has been suggested from combination schedules with bevacizumab. Panitumumab has been recently approved for CC. Although there is limited clinical experience, the latest data have confirmed its activity in heavily pretreated patients resulting in a clinical benefit vs. best support care. In spite of the clinical benefits, adverse events and the high sanitary cost derived from these drugs force the selection of patients with the highest probability of benefit. At the moment, when EGFR expression evidenced by immunohistochemistry has no va...Continue Reading

References

Dec 1, 1990·The British Journal of Surgery·R J SteeleO Eremin
Aug 16, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A de GramontA Bonetti
Mar 20, 2001·Critical Reviews in Oncology/hematology·X D YangC G Davis
Jul 4, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M HidalgoE K Rowinsky
May 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Malcolm RansonEric K Rowinsky
Sep 14, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roy S HerbstPatricia Mucci LoRusso
Dec 3, 2002·International Journal of Radiation Oncology, Biology, Physics·Jordi GiraltInes de Torres
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leonard B SaltzRobert J Mayer
Jun 4, 2004·The New England Journal of Medicine·Herbert HurwitzFairooz Kabbinavar
Jun 23, 2004·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Derek AtkinsStephan Störkel
Jul 23, 2004·The New England Journal of Medicine·David CunninghamEric Van Cutsem
Oct 7, 2004·Journal of the National Cancer Institute·Jessica B O'ConnellClifford Y Ko
Oct 12, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wells A MessersmithManuel Hidalgo
Dec 16, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J-P SpanoP Wind
Dec 31, 2004·The New England Journal of Medicine·Thomas D BarberVictor E Velculescu
Jan 26, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J P SpanoG Milano
Jan 29, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ki Young ChungLeonard B Saltz
Feb 24, 2005·Seminars in Oncology·A Craig LockhartJordan D Berlin
Mar 2, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alberto Sobrero, Paolo Bruzzi
Mar 5, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hisashi NagaharaMasaki Mori
May 4, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fairooz F KabbinavarSomnath Sarkar
May 24, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel VallböhmerHeinz-Josef Lenz
Jul 15, 2005·The New England Journal of Medicine·Zenta TsuchihashiPasi A Jänne
Aug 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Timothy KuoBranimir I Sikic
Sep 17, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shuji OginoCharles S Fuchs
Dec 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mace L RothenbergRobert J Coffey
Mar 30, 2006·British Journal of Cancer·C A TownsleyA M Oza
Apr 19, 2006·Cancer Research·Astrid LièvrePierre Laurent-Puig
Apr 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey A MeyerhardtCharles S Fuchs
Aug 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John D HainsworthF Anthony Greco
Oct 10, 2006·Clinical Colorectal Cancer·Brian M WolpinCharles S Fuchs
Oct 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jonathan L Hecht, George L Mutter
Oct 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Heinz-Josef LenzEric K Rowinsky
Jan 12, 2007·Cancer Chemotherapy and Pharmacology·Jeffrey A MeyerhardtCharles S Fuchs
Jan 24, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·I ChauA Swaisland
May 2, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric Van CutsemRafael G Amado
May 8, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J A MeyerhardtD P Ryan
May 12, 2007·Clinical Advances in Hematology & Oncology : H&O·Kari B WisinskiAl B Benson
Aug 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shirin Khambata-FordDavid J Mauro

❮ Previous
Next ❯

Citations

Aug 3, 2012·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Pilar García-AlfonsoUNKNOWN Spanish Society of Pathology (SEAP)
Feb 23, 2011·International Journal of Molecular Sciences·Larissa BelovRichard I Christopherson
Jul 17, 2013·Expert Opinion on Therapeutic Targets·Liu HongLubi Brain
Oct 8, 2011·Journal of the Korean Society of Coloproctology·Ji Hun GwakKwang Ho Kim
Nov 28, 2013·BMC Gastroenterology·Hailong CaoBangmao Wang
Dec 3, 2016·Annals of Surgical Treatment and Research·Bo Young OhRyung-Ah Lee
Nov 14, 2019·Journal of Pathology and Translational Medicine·Baek-Hui KimYoun Wha Kim
Aug 11, 2011·Journal of the Korean Society of Coloproctology·Bo-Young OhKwang Ho Kim
Nov 10, 2020·Journal of Cellular Biochemistry·Qian GouJuanjuan Shi
Oct 2, 2009·Archives of Pathology & Laboratory Medicine·Federico A MonzonMarina N Nikiforova

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
John Mendelsohn, Jose Baselga
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Román Pérez-SolerPhilip Bonomi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Leonard B SaltzRobert J Mayer
© 2021 Meta ULC. All rights reserved